Can Cotiviti further penetrate and cross sell its existing clients to drive continued growth? Report Available: April 5, 2018 Blueshift’s initial research found healthcare and medical claims growth moving in a direction favorable for claims auditing expert COTV. With 20 of the top 25 health insurers on board as clients, COTV’s strong track record of […]
Research Question: How soon until Amazon’s ventures into the sales and distribution of prescription drug and medical/dental supplies disrupt traditional channels? Companies: ABC, AET, AMZN, BRK.A/B, CAH, COST, CVS, ESRX, HSIC, JPM, MCK, OMI, PDCO, TGT, WBA, WMT, XRAY By: David Franklin Click here to download report (.pdf) Summary of Findings com Inc. (AMZN) […]
Research Question: Will WageWorks’ organic growth continue at its projected pace of 9% to 14%? Companies: ANTM, BNFT, CNDT, FITB, HQY, MMC, TNET, UMBF, WAGE, WLTW By: Reverdy Johnson Click here to download report (.pdf) Summary of Findings An additional interview with a benefits manager for a financial services firm with nearly 5,000 employees […]
Research Question: Will WageWorks’ organic growth continue at its projected pace of 9% to 14%? Companies: BNFT, CNDT, HQY, MMC, TNET, UMBF, WAGE, WLTW By: Reverdy Johnson Click here to download report (.pdf) Summary of Findings WageWorks Inc. (WAGE) is more likely to see its growth come from acquisitions rather than organically. Seven of […]
Will Wageworks’ organic growth continue at its projected pace of 9% to 14%? Report Available:October 25, 2017 Blueshift’s initial research found a trend toward high-deductible health plans and growth in the consumer-directed benefits market. WAGE is the leader in this space and enters the enterprise selling season with solid growth in RFPs, while […]
Will long acting implantable and injectable buprenorphine become widely adopted for opioid addiction treatment? Report Available: April 8, 2016 Blueshift’s initial research shows that addiction to opioids has skyrocketed to the point of being an epidemic. Current available treatment options face numerous challenges including frequent dosing, poor adherence, high incidence of relapse, and misuse. […]
Research Question: Does shifting to a private exchange offer a compelling value proposition for self-insured companies as they seek to control health insurance costs? Companies: AET, CI, CVG, HUM, MMC, TW, UNH, WAG, WLP, XRX By: David Franklin Click here to download the report (.pdf) Summary of Findings Private health insurance exchanges, self-funded health insurance, and defined […]
Copyright © 2015 Blueshift Research, LLC. All rights reserved.
Connect with Us!